New Blood Test to Detect Kidney Transplant Rejection
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a kidney transplant recipient or about to receive a new kidney (from a living or deceased donor).
- You are an adult, 18 years or older.
- You are willing and able to sign a consent form (paper or electronic) agreeing to take part in this study.
- You must be treated at a specific hospital (St. Orsola Hospital in Bologna).
- (A separate group includes healthy blood donors, but that group does not require your consent.)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from kidney transplant patients who have a specific type of long-term rejection called chronic active humoral rejection (cAMR). It aims to better understand the condition and help future patients.
This study tests a new blood test (called cfDNA) that may help doctors detect early signs of kidney transplant rejection before problems develop. The goal is to help keep your transplanted kidney healthy longer by catching issues early.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This trial is testing a new blood test called T-ID that monitors your immune system after a kidney transplant. It may help doctors detect early signs of rejection so they can adjust your treatment before problems start.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.